JP2021513857A5 - - Google Patents
Info
- Publication number
- JP2021513857A5 JP2021513857A5 JP2020543928A JP2020543928A JP2021513857A5 JP 2021513857 A5 JP2021513857 A5 JP 2021513857A5 JP 2020543928 A JP2020543928 A JP 2020543928A JP 2020543928 A JP2020543928 A JP 2020543928A JP 2021513857 A5 JP2021513857 A5 JP 2021513857A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cells
- domain
- acid sequence
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862634435P | 2018-02-23 | 2018-02-23 | |
| US62/634,435 | 2018-02-23 | ||
| US201862677783P | 2018-05-30 | 2018-05-30 | |
| US62/677,783 | 2018-05-30 | ||
| PCT/US2019/019065 WO2019165156A1 (en) | 2018-02-23 | 2019-02-22 | Cd83-binding chimeric antigen receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513857A JP2021513857A (ja) | 2021-06-03 |
| JP2021513857A5 true JP2021513857A5 (enExample) | 2022-02-28 |
| JP7358369B2 JP7358369B2 (ja) | 2023-10-10 |
Family
ID=67686942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543928A Active JP7358369B2 (ja) | 2018-02-23 | 2019-02-22 | Ｃｄ８３結合キメラ抗原受容体 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12492254B2 (enExample) |
| EP (1) | EP3755722A4 (enExample) |
| JP (1) | JP7358369B2 (enExample) |
| KR (1) | KR20200130324A (enExample) |
| CN (1) | CN112004832A (enExample) |
| AU (1) | AU2019226101A1 (enExample) |
| BR (1) | BR112020017015A2 (enExample) |
| IL (1) | IL276836A (enExample) |
| MA (1) | MA51917A (enExample) |
| MX (1) | MX2020008803A (enExample) |
| PH (1) | PH12020500632A1 (enExample) |
| SG (1) | SG11202007755YA (enExample) |
| WO (1) | WO2019165156A1 (enExample) |
| ZA (1) | ZA202005837B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12492254B2 (en) | 2018-02-23 | 2025-12-09 | H. Lee Moffitt Cancer Center and Research Intitute. Inc. | CD83-binding chimeric antigen receptors |
| CA3147835A1 (en) * | 2019-08-16 | 2021-02-25 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Chimeric antigen receptors for treating myeloid malignancies |
| EP4013447A4 (en) * | 2019-08-16 | 2024-05-29 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | T CELLS EXPRESSING A CHIMERIC ANTI-CD83 ANTIGEN RECEPTOR |
| US11802159B2 (en) * | 2019-09-30 | 2023-10-31 | The Trustees Of The University Of Pennsylvania | Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeric antigen receptors (CARs) |
| US20230051885A1 (en) * | 2019-12-18 | 2023-02-16 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Systems and Methods for Producing Efficacious Regulatory T Cells |
| WO2021150970A1 (en) * | 2020-01-22 | 2021-07-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Bi-specific chimeric antigen receptor t cells targeting cd83 and interleukin 6 receptor |
| WO2021168421A1 (en) * | 2020-02-20 | 2021-08-26 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Method of enhancing immunotherapy using er stress pathway inhibitors |
| WO2022036224A1 (en) * | 2020-08-14 | 2022-02-17 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Chimeric antigen receptor t cells for treating autoimmunity |
| WO2022183160A1 (en) * | 2021-02-25 | 2022-09-01 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Methods for treating cd83-expressing cancer |
| WO2022260909A1 (en) * | 2021-06-09 | 2022-12-15 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Methods of using anti-cd83 chimeric antigen receptor expressing t cells |
| CN119331093B (zh) * | 2024-11-04 | 2025-07-11 | 武汉伊莱瑞特生物科技股份有限公司 | 一种抗CD30的兔源Fab抗体及其制备方法和应用 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040185040A1 (en) | 2001-11-21 | 2004-09-23 | Celltech R & D Limited | Modulating immune responses |
| EP1572976B1 (en) | 2002-11-21 | 2010-09-15 | Celltech R & D, Inc. | Modulating immune responses |
| GB0624500D0 (en) | 2006-12-07 | 2007-01-17 | Istituto Superiore Di Sanito | A novel passive vaccine for candida infections |
| WO2009155477A1 (en) | 2008-06-19 | 2009-12-23 | The Trustees Of The University Of Pennsylvania | Inducible regulatory t-cell generation for hematopoietic transplants |
| CN104906139B (zh) | 2011-01-10 | 2020-10-23 | 小利兰·斯坦福大学托管委员会 | 异源造血干细胞移植的增强 |
| JP2013150592A (ja) * | 2011-07-01 | 2013-08-08 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| JP2013040160A (ja) | 2011-07-01 | 2013-02-28 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| AU2014213009B2 (en) * | 2013-02-01 | 2019-01-03 | Kira Biotech Pty Limited | Anti-CD83 antibodies and use thereof |
| AU2014223602C1 (en) | 2013-02-26 | 2018-11-08 | Axiomx, Inc. | Methods for the production of libraries for directed evolution |
| CA2923553C (en) | 2013-09-13 | 2023-05-23 | Soligenix, Inc. | Novel peptides and analogs for use in the treatment of oral mucositis |
| AU2015336931B2 (en) * | 2014-10-23 | 2021-04-29 | Kira Biotech Pty Limited | CD83 binding proteins and uses thereof |
| PL3212225T3 (pl) * | 2014-10-31 | 2026-03-30 | The Trustees Of The University Of Pennsylvania | Sposoby i kompozycje zmodyfikowanych limfocytów t |
| CA2874083C (en) | 2014-12-05 | 2024-01-02 | Universite Laval | Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases |
| WO2016126608A1 (en) * | 2015-02-02 | 2016-08-11 | Novartis Ag | Car-expressing cells against multiple tumor antigens and uses thereof |
| PL3280729T3 (pl) | 2015-04-08 | 2022-08-22 | Novartis Ag | Terapie cd20, terapie cd22 i terapie skojarzone komórką eksprymującą chimeryczny receptor antygenowy (car) cd19 |
| AU2016274989A1 (en) | 2015-06-12 | 2017-11-02 | Immunomedics, Inc. | Disease therapy with chimeric antigen receptor (car) constructs and t cells (car-t) or nk cells (car-nk) expressing car constructs |
| TWI833684B (zh) | 2015-06-25 | 2024-03-01 | 美商生物細胞基因治療有限公司 | 嵌合抗原受體（ｃａｒ）、組合物及其使用方法 |
| SG11201807489PA (en) * | 2016-03-04 | 2018-09-27 | Novartis Ag | Cells expressing multiple chimeric antigen receptor (car) molecules and uses therefore |
| CA3042613A1 (en) | 2016-11-11 | 2018-05-17 | Autolus Limited | Chimeric antigen receptor |
| KR20200066613A (ko) | 2017-09-13 | 2020-06-10 | 키라 바이오테크 피티와이 리미티드 | 치료 방법 |
| CA3076337A1 (en) | 2017-09-19 | 2019-03-28 | Massachusetts Institute Of Technology | Compositions for chimeric antigen receptor t cell therapy and uses thereof |
| WO2019099639A1 (en) | 2017-11-15 | 2019-05-23 | Navartis Ag | Bcma-targeting chimeric antigen receptor, cd19-targeting chimeric antigen receptor, and combination therapies |
| WO2019136335A1 (en) | 2018-01-05 | 2019-07-11 | Gencyte Therapeutics, Inc. | Precision molecular adaptor system for car-t immunotherapy |
| ES3012854T3 (en) | 2018-02-08 | 2025-04-10 | Univ Leland Stanford Junior | Allogenic hematopoietic stem cell transplantation |
| US20200108098A1 (en) | 2018-02-23 | 2020-04-09 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Anti-cd83 chimeric antigen receptor expressing t regulatory cells |
| US12492254B2 (en) | 2018-02-23 | 2025-12-09 | H. Lee Moffitt Cancer Center and Research Intitute. Inc. | CD83-binding chimeric antigen receptors |
| US20200268797A1 (en) | 2018-11-30 | 2020-08-27 | Janssen Biotech, Inc. | Gamma delta t cells and uses thereof |
| EP4013447A4 (en) | 2019-08-16 | 2024-05-29 | H. Lee Moffitt Cancer Center & Research Institute, Inc. | T CELLS EXPRESSING A CHIMERIC ANTI-CD83 ANTIGEN RECEPTOR |
| US20230051885A1 (en) | 2019-12-18 | 2023-02-16 | H. Lee Moffitt Cancer Center And Research Institute Inc. | Systems and Methods for Producing Efficacious Regulatory T Cells |
| WO2021150970A1 (en) | 2020-01-22 | 2021-07-29 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Bi-specific chimeric antigen receptor t cells targeting cd83 and interleukin 6 receptor |
| US20250052748A1 (en) | 2021-12-22 | 2025-02-13 | Regents Of The University Of Minnesota | Cd83 and allo- and autoimmune conditions |
| JP2024102735A (ja) | 2023-01-19 | 2024-07-31 | セイコーエプソン株式会社 | 頭部装着型表示装置及び光学ユニット |
-
2019
- 2019-02-22 US US16/969,056 patent/US12492254B2/en active Active
- 2019-02-22 CN CN201980027877.0A patent/CN112004832A/zh active Pending
- 2019-02-22 AU AU2019226101A patent/AU2019226101A1/en not_active Abandoned
- 2019-02-22 JP JP2020543928A patent/JP7358369B2/ja active Active
- 2019-02-22 MA MA051917A patent/MA51917A/fr unknown
- 2019-02-22 EP EP19757555.8A patent/EP3755722A4/en active Pending
- 2019-02-22 SG SG11202007755YA patent/SG11202007755YA/en unknown
- 2019-02-22 MX MX2020008803A patent/MX2020008803A/es unknown
- 2019-02-22 KR KR1020207027148A patent/KR20200130324A/ko not_active Ceased
- 2019-02-22 WO PCT/US2019/019065 patent/WO2019165156A1/en not_active Ceased
- 2019-02-22 BR BR112020017015-1A patent/BR112020017015A2/pt not_active IP Right Cessation
-
2020
- 2020-08-19 PH PH12020500632A patent/PH12020500632A1/en unknown
- 2020-08-20 IL IL276836A patent/IL276836A/en unknown
- 2020-09-21 ZA ZA2020/05837A patent/ZA202005837B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021087455A5 (enExample) | ||
| JP2021177771A5 (enExample) | ||
| JP2021094037A5 (enExample) | ||
| JP2025028239A5 (enExample) | ||
| JP2020114264A5 (enExample) | ||
| JP2019527557A5 (enExample) | ||
| JP2020517295A5 (enExample) | ||
| JP2025065142A5 (enExample) | ||
| JP2022544581A5 (enExample) | ||
| HRP20241057T1 (hr) | Kimerni antigenski receptori na osnovu jedno-domenskih antitijela i načini njihove uporabe | |
| JP2020530289A5 (enExample) | ||
| JP2017524367A5 (enExample) | ||
| IL317912A (en) | A combined chimeric antigen receptor targeting CD19 and CD20 and its applications | |
| IL277398B1 (en) | Pd-l1 binding affimers, and uses related thereto | |
| JP2024023228A5 (enExample) | ||
| JP2022548778A5 (enExample) | ||
| HRP20231542T1 (hr) | Kimerni antigenski receptori koji ciljaju bcma i postupci njihove uporabe | |
| JP2020513754A5 (enExample) | ||
| JP2022542543A5 (enExample) | ||
| JP2023544890A5 (enExample) | ||
| TW201920653A (zh) | 調節細胞表達的生物活性之結合分子 | |
| JP2022507295A5 (enExample) | ||
| JP2022542559A5 (enExample) | ||
| JP2018526028A5 (enExample) | ||
| JP2024527557A5 (enExample) |